Literature DB >> 18935841

IV therapy: recognizing the differences between infiltration and extravasation.

Lisa Dougherty1.   

Abstract

Infiltration and extravasation are complications that can occur during intravenous therapy administered via either peripheral or central venous access devices. Both can result in problems with the siting of future venous access devices, nerve damage, infection and tissue necrosis. The nurse is the key to reducing the risk of infiltration and extravasation, through her knowledge and skill in cannulation and the intravenous administration of drugs (by bolus injection or infusion). The nurse must also be able to recognize the early signs and symptoms of infiltration and extravasation and act promptly and effectively to limit tissue damage. The first sign of possible leakage of drugs into the tissues is pain and discomfort, so patients must be informed of what symptoms to look out for and be asked to report any change in sensation as soon as they are aware of it. Finally, accurate documentation of the event is vital to facilitate patient care and in case of litigation.

Entities:  

Mesh:

Year:  2008        PMID: 18935841     DOI: 10.12968/bjon.2008.17.14.30656

Source DB:  PubMed          Journal:  Br J Nurs        ISSN: 0966-0461


  10 in total

Review 1.  Overview, prevention and management of chemotherapy extravasation.

Authors:  Firas Y Kreidieh; Hiba A Moukadem; Nagi S El Saghir
Journal:  World J Clin Oncol       Date:  2016-02-10

2.  Skin staining following intravenous iron infusion.

Authors:  Clare Margaret Crowley; Gabriela McMahon; Joanna Desmond; Mendinaro Imcha
Journal:  BMJ Case Rep       Date:  2019-06-06

3.  Accidental infusion leakage at subgalea in infants: report of 6 cases.

Authors:  Bo An; Haojie Ning
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  Central venous port systems as an integral part of chemotherapy.

Authors:  Ulf K Teichgräber; Robert Pfitzmann; Herbert A F Hofmann
Journal:  Dtsch Arztebl Int       Date:  2011-03-04       Impact factor: 5.594

5.  Adverse drug events in an intensive care unit of a university hospital.

Authors:  Adriano Max Moreira Reis; Silvia Helena De Bortoli Cassiani
Journal:  Eur J Clin Pharmacol       Date:  2011-01-19       Impact factor: 2.953

Review 6.  Clinical Applications of Hyaluronidase.

Authors:  Gregor Cornelius Weber; Bettina Alexandra Buhren; Holger Schrumpf; Johannes Wohlrab; Peter Arne Gerber
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

7.  Prevalence of difficult venous access and associated risk factors in highly complex hospitalised patients.

Authors:  Victoria Armenteros-Yeguas; Lucía Gárate-Echenique; Maria Aranzazu Tomás-López; Estíbaliz Cristóbal-Domínguez; Breno Moreno-de Gusmão; Erika Miranda-Serrano; Maria Inmaculada Moraza-Dulanto
Journal:  J Clin Nurs       Date:  2017-03-28       Impact factor: 3.036

Review 8.  Upper limb extravasation of cytotoxic drugs: results of the saline washout technique in children.

Authors:  Virginie Mas; Anne Laure Simon; Ana Presedo; Cindy Mallet; Brice Ilharreborde; Pascal Jehanno
Journal:  J Child Orthop       Date:  2020-06-01       Impact factor: 1.548

Review 9.  Vascular access specialist teams for device insertion and prevention of failure.

Authors:  Peter J Carr; Niall S Higgins; Marie L Cooke; Gabor Mihala; Claire M Rickard
Journal:  Cochrane Database Syst Rev       Date:  2018-03-20

10.  Evaluation of the Predictive Validity of Thermography in Identifying Extravasation With Intravenous Chemotherapy Infusions.

Authors:  Yuko Matsui; Ryoko Murayama; Hidenori Tanabe; Makoto Oe; Yoshiharu Motoo; Takanori Wagatsuma; Michiko Michibuchi; Sachiko Kinoshita; Keiko Sakai; Chizuko Konya; Junko Sugama; Hiromi Sanada
Journal:  J Infus Nurs       Date:  2017 Nov/Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.